Clinical Trial

Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)

Name: Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT) — clinical trial record (NCT07759362)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The primary purpose of this study is to assess the efficacy, safety, and tolerability of KN3835 compared to placebo in the treatment of flexible/semi-flexible HMT.

Trial Details

NCT Number	NCT07759362
Lead Sponsor	Endo USA Inc., a Keenova Therapeutics Company
Conditions	Flexible Hammertoe, Semi-flexible Hammertoe
Enrollment	554 participants
Start Date	2026-08
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-12